While much of the focus has been on the Detroit Three during the current U.S. sales downturn, signs of turmoil have emerged in recent months for transplant auto makers, which quietly have been scaling back production volumes and uncharacteristically falling short of output schedules. The cutbacks come despite still aggressive capacity expansion plans that will see at least four new vehicle-assembly plants come on stream between now and mid-2010. Although Toyota Motor Engineering and ...
Premium Content (PAID Subscription Required)
"Soft U.S. Market Taking Toll on Transplant Production" is part of the paid WardsAuto Premium content. You must log in with Premium credentials in order to access this article. Premium paid subscribers also gain access to:
All of WardsAuto's reliable, in-depth industry reporting and analysis
Hundreds of downloadable data tables including:
• Global sales and production data by country
• U.S. model-line inventory data
• Engine and equipment installation rates
• WardsAuto's North America Plant by Platform forecast
• Product Cycle chart
• Interrelationships among major OEMs
• Medium- and heavy-duty truck volumes
• Historical data and much more!
Current subscribers, please login or CLICK for support information.